サポート ブログ Top 10 Antibody Drug Approvals from FDA 2023

Top 10 Antibody Drug Approvals from FDA 2023

Biointron 2024-01-20 Read time: 3 mins
FDA.jpg
Image credit: Adobe Stock

Antibodies are an essential part of our immune system, and over the years, scientists have developed a range of antibody-based drugs that are used to treat various diseases. In recent years, many antibody drugs have received approval from the US Food and Drug Administration (FDA) for their safety and effectiveness. Here are the top 10 antibody drugs approved by the FDA: 

  1. Humira (adalimumab): This antibody drug is used to treat a range of autoimmune diseases, including rheumatoid arthritis and psoriasis. 

  2. Rituxan (rituximab): This antibody drug is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. 

  3. Avastin (bevacizumab): This antibody drug is used to treat certain types of cancer, including colon, lung, and brain cancer. 

  4. Herceptin (trastuzumab): This antibody drug is used to treat HER2-positive breast cancer. 

  5. Remicade (infliximab): This antibody drug is used to treat autoimmune diseases, including Crohn's disease and rheumatoid arthritis. 

  6. Keytruda (pembrolizumab): This antibody drug is used to treat various types of cancer, including melanoma, lung cancer, and head and neck cancer. 

  7. Opdivo (nivolumab): This antibody drug is used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. 

  8. Erbitux (cetuximab): This antibody drug is used to treat colon cancer and head and neck cancer. 

  9. Prolia (denosumab): This antibody drug is used to treat osteoporosis. 

  10. Xolair (omalizumab): This antibody drug is used to treat asthma and allergic rhinitis. 

At Biointron, we offer high-quality recombinant antibody production services that can help researchers and biotech companies develop antibody-based drugs for various diseases. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.

Subscribe to our ブログ

Recent ブログ

Antibody specificity refers to an antibody's ability to selectively bind to a unique epitope on a target antigen while avoiding interactions with unrelated antigens. This property arises from the highly specialized antigen-binding site located in the variable region of the antibody, which determines its unique binding characteristics.

Dec 20, 2024
ブログ

Antibody affinity refers to the strength of the binding interaction between a single antigen epitope and the paratope (binding site) of an antibody. This interaction is a fundamental measure of how well an antibody recognizes its specific antigen target.

Dec 20, 2024
ブログ

Recombinant antibodies are produced using genetic engineering techniques, unlike traditional antibody production, where the immune system generates antibodies without direct control over their sequence. By introducing genes encoding antibody fragments into host cells, such as bacteria or mammalian cells, recombinant antibodies can be expressed, purified, and deployed for applications including research, diagnostics, and therapeutics.

Dec 19, 2024
ブログ

Recombinant antibody expression is a biotechnological process that involves engineering and producing antibodies outside their natural context using recombinant DNA technology.

Dec 19, 2024
ブログ

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。